Your browser doesn't support javascript.
loading
COOBoostR: An Extreme Gradient Boosting-Based Tool for Robust Tissue or Cell-of-Origin Prediction of Tumors.
Yang, Sungmin; Ha, Kyungsik; Song, Woojeung; Fujita, Masashi; Kübler, Kirsten; Polak, Paz; Hiyama, Eiso; Nakagawa, Hidewaki; Kim, Hong-Gee; Lee, Hwajin.
Afiliação
  • Yang S; Biomedical Knowledge Engineering Laboratory, Seoul National University, Seoul 08826, Republic of Korea.
  • Ha K; Dental Research Institute, Seoul National University, Seoul 08826, Republic of Korea.
  • Song W; Department of Medicine, Hanyang University, Seoul 04763, Republic of Korea.
  • Fujita M; Laboratory of Cancer Genomics, RIKEN Center for Integrated Medical Sciences, Yokohama 230-0045, Japan.
  • Kübler K; Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany.
  • Polak P; Department of Hematology, Oncology and Cancer Immunology, Charité-Universitätsmedizin Berlin, Hindenburgdamm 30, 12203 Berlin, Germany.
  • Hiyama E; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
  • Nakagawa H; Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA 02129, USA.
  • Kim HG; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA.
  • Lee H; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, 1425 Madison Ave., New York, NY 10029, USA.
Life (Basel) ; 13(1)2022 Dec 27.
Article em En | MEDLINE | ID: mdl-36676020
ABSTRACT
We present here COOBoostR, a computational method designed for the putative prediction of the tissue- or cell-of-origin of various cancer types. COOBoostR leverages regional somatic mutation density information and chromatin mark features to be applied to an extreme gradient boosting-based machine-learning algorithm. COOBoostR ranks chromatin marks from various tissue and cell types, which best explain the somatic mutation density landscape of any sample of interest. A specific tissue or cell type matching the chromatin mark feature with highest explanatory power is designated as a potential tissue- or cell-of-origin. Through integrating either ChIP-seq based chromatin data, along with regional somatic mutation density data derived from normal cells/tissue, precancerous lesions, and cancer types, we show that COOBoostR outperforms existing random forest-based methods in prediction speed, with comparable or better tissue or cell-of-origin prediction performance (prediction accuracy-normal cells/tissue 76.99%, precancerous lesions 95.65%, cancer cells 89.39%). In addition, our results suggest a dynamic somatic mutation accumulation at the normal tissue or cell stage which could be intertwined with the changes in open chromatin marks and enhancer sites. These results further represent chromatin marks shaping the somatic mutation landscape at the early stage of mutation accumulation, possibly even before the initiation of precancerous lesions or neoplasia.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article